Integrative Multi-omics Analysis to Predict Monoclonal Gammopathies Clinical Evolution

Clinical trial NCT07214324 · RECRUITING

Trial details

NCT number: NCT07214324
Sponsor: Azienda USL Reggio Emilia - IRCCS
Status: RECRUITING
Study type: OBSERVATIONAL

Monoclonal Gammopathy of Undetermined Significance (MGUS)Smoldering Multiple Myeloma (SMM)Multiple Myeloma (MM)

Start date: 2025-03-17
Primary completion: 2025-08-12
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.